TAYLOR BRADFORD: Open Payments
NPI 1790303352 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 88 payments from 24 companies in 2025. Trend: 2023 $1,657 · 2024 $1,379 · 2025 $1,740
Food & beverage: $1,655Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $427 |
| AstraZeneca Pharmaceuticals LP | 6 | $209 |
| Phathom Pharmaceuticals, Inc. | 5 | $180 |
| PFIZER INC. | 11 | $162 |
| Lilly USA, LLC | 9 | $125 |
| Astellas Pharma US Inc | 2 | $105 |
| Novo Nordisk Inc | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
Products named: VOQUEZNA, VRAYLAR, QULIPTA, BREZTRI, NURTEC ODT, MOUNJARO, UBRELVY, ELIQUIS.
Industry payments across LA — which companies pay providers there.
